CNS Anticancer Drug Discovery and Development: 2016 conference insights.

Levin, Victor A; Abrey, Lauren E; Heffron, Timothy P; Tonge, Peter J; Dar, Arvin C; Weiss, William A; Gallo, James M

Levin, Victor A; Abrey, Lauren E; Heffron, Timothy P; Tonge, Peter J; Dar, Arvin C; Weiss, William A; Gallo, James M.

Afiliação

Levin VA; Department of Neurosurgery, University of California San Francisco, San Francisco, CA, 94143, USA.
Abrey LE; Department of Neuro-Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.
Heffron TP; Hoffman-La Roche Ltd, Basel, Switzerland.
Tonge PJ; Senior Scientist, Genentech, South San Francisco, CA 94080, USA.
Dar AC; Department of Chemistry, Stony Brook University, Stony Brook, NY 11794, USA.
Weiss WA; Oncological & Pharmacological Sciences, Mount Sinai Icahn School of Medicine, New York, NY 10029, USA.
Gallo JM; Department of Neurology, University of California San Francisco, San Francisco, CA 949143, USA (W.A.W.), CA, USA.

CNS Oncol ; 6(3): 167-177, 2017 Jul.

Article em En | MEDLINE | ID: mdl-28718326

Palavras-chave

academia; chemotherapy; gliomas; medulloblastoma; neuro-oncology; pharmaceutical industry

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: CNS Oncol Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google